Histopathological features of peripheral nerve and muscle in mitochondrial disease

Seminars in Neurology

Volumn 21, Issue 3, 2001, Pages 293-301

  Sladky, J T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytochrome oxidase; Demyelinating neuropathy; Electrodiagnostic testing; Histopathology; Mitochondria; Muscle biopsy; Nerve biopsy; Node of Ranvier; Paracrystalline inclusions; Ragged red fiber; Succinate dehydrogenase

Indexed keywords

CYTOCHROME C OXIDASE; SUCCINATE DEHYDROGENASE;

CELL INCLUSION; DEMYELINATING NEUROPATHY; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; GENOTYPE; HISTOPATHOLOGY; HUMAN; MUSCLE; MUSCLE BIOPSY; NERVE BIOPSY; NERVE CONDUCTION; PERIPHERAL NERVE; PHENOTYPE; PRIORITY JOURNAL; RANVIER NODE; REVIEW;

EDUCATION, MEDICAL, CONTINUING; HUMANS; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; PERIPHERAL NERVES;

EID: 0034770539     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17946     Document Type: Review

References (55)

1. Mitochondrial respiratory chain disorders II: Neurodegenerative disorders and nuclear gene defects
2. Mitochondrial encephalopathies
3. Mitochondrial DNA defects: A widening clinical spectrum of disorders
4. Mitochondrial encephalomyopathies
5. Mitochondrial myopathies
6. Disorders of mitochondria and related metabolism
7. Nuclear gene defects in mitochondrial disorders
8. Molecular basis of mitochondrial DNA disease
9. Clinical spectrum of mitochondrial diseases
10. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA
11. Mitochondrial DNA (mtDNA) diseases: Correlation of genotype to phenotype
12. Mitochondrial myopathies and encephalomyopathies
13. Maternally inherited cardiomyopathy: A new phenotype associated with the A to G AT nt.3243 of mitochondrial DNA (MELAS mutation)
14. Differential features of patients with mutations in two COX assembly genes, SURF-1 and SCO2
15. Mitochondrial DNA mutations in epilepsy and neurological disease
16. Clinical spectrum of the MELAS mutation in a large pedigree
17. Protean manifestations of mitochondrial diseases: A minireview
18. Cardiac involvement in mitochondrial diseases: A study on 17 patients with documented mitochondrial DNA defects
19. Kearns-Sayre syndrome associated with mitochondrial DNA deletion or duplication: A molecular genetic and pathological study
20. Ocular clinicopathologic study of the mitochondrial encephalomyopathy overlap syndromes
21. The atypical pigmentary retinopathy of Kearns-Sayre syndrome: A light and electron microscopic study
22. Progressive brainstem and white matter lesions in Kearns-Sayre syndrome: A case report
23. Neuropathology in Kearns-Sayre syndrome
24. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: A slip-replication model and metabolic therapy
25. Hearing impairment and the Kearns-Sayre syndrome
26. Kearns-Sayre syndrome and dilated cardiomyopathy
27. Sinus dysrhythmia in Kearns-Sayre syndrome
28. Mitochondrial DNA mutations in diseases of energy metabolism
29. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes
30. Deletions of mitochondrial DNA in Kearns-Sayre syndrome: 1988
31. Mitochondrial respiratory chain disorders and the liver
32. Mitochondrial encephalomyopathies preceded by de-Toni-Debre-Fanconi syndrome or focal segmental glomerulosclerosis
33. Hematologic involvement in mitochondrial cytopathies in childhood: A retrospective study of bone marrow smears
34. Myopathy, lactic acidosis, and sideroblastic anemia: A new syndrome
35. Multiple deletions of mtDNA in two brothers with sideroblastic anemia and mitochondrial myopathy and in their asymptomatic mother
36. Kearns-Sayre syndrome with sideroblastic anemia: Molecular investigations
37. Mitochondria and skin disease
38. Age related biology and disease of muscle and nerve
39. Childhood encephalopathies and myopathies: A prospective study in a defined population to assess the frequency of mitochondrial disorders
40. A large-scale deletion of mitochondrial DNA in a case with pure mitochondrial myopathy and neuropathy
41. Mitochondrial creatine kinase: A major constituent of pathological inclusions seen in mitochondrial myopathies
42. Suramin-induced weakness from hypophosphatemia and mitochondrial myopathy: Association of suramin with mitochondrial toxicity in humans
43. Frataxin gene of Friedreich's ataxia is targeted to mitochondria
44. Aspects of neuropathy in mitochondrial diseases
45. Peripheral neuropathy in mitochondrial encephalomyopathies
46. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease
47. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder
48. Tissue mosaicism in the skeletal muscle and sural nerve biopsies in the MELAS syndrome
49. A case of mitochondrial myopathy with MELAS-like features and polyneuropathy: Ultrastructural and molecular studies
50. Muscle-nerve involvement in autosomal dominant progressive external ophthalmoplegia with hypogonadism
51. Peripheral neuropathy of mitochondrial myopathies
52. Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA
53. Neuropathy associated with mitochondrial disorders
54. Mitochondrial cytopathy presenting as hereditary sensory neuropathy with progressive external ophthalmoplegia, ataxia and fatal myoclonic epileptic status
55. Increase of mitochondria in vasa nervorum of cases with mitochondrial myopathy, Kearns-Sayre syndrome, progressive external ophthalmoplegia and MELAS